Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0G7MJ
|
|||
Former ID |
DNC011318
|
|||
Drug Name |
NSC-640556
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C28H20N4O3S
|
|||
Canonical SMILES |
CC1=C(SC(=N1)N2C(=CC(=N2)C3=CC=CC=C3)C4=CC=CC=C4)C(=O)C=CC5=CC=C(C=C5)[N+](=O)[O-]
|
|||
InChI |
1S/C28H20N4O3S/c1-19-27(26(33)17-14-20-12-15-23(16-13-20)32(34)35)36-28(29-19)31-25(22-10-6-3-7-11-22)18-24(30-31)21-8-4-2-5-9-21/h2-18H,1H3/b17-14+
|
|||
InChIKey |
IPRWXFAJXPKDLK-SAPNQHFASA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Quinone reductase 2 (NQO2) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2). Bioorg Med Chem Lett. 2010 Dec 15;20(24):7331-6. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.